BURLINGTON, Mass.--(BUSINESS WIRE)--Nov 7, 2023--Cardurion Pharmaceuticals, Inc. (鈥淐ardurion鈥� or 鈥渢he Company鈥�), a clinical-stage biotechnology company focused on the discovery and development of novel, next-generation therapeutics for the treatment of cardiovascular diseases, today ...
MANASSAS, Va.--(BUSINESS WIRE)--Nov 7, 2023--<a ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Nov 7, 2023--Whiterabbit.ai, an AI-technology company dedicated to making late-stage diseases a rarity, today announced its collaboration with the American College of Radiology 庐 (ACR 庐 ) Data Science Institute鈩� (DSI鈩�) to make its AI-driven breast ...
PRINCETON, N.J.--(BUSINESS WIRE)--Nov 7, 2023--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will report third quarter 2023 financial results on November ...
FRANKLIN, Tenn.--(BUSINESS WIRE)--Nov 7, 2023--<a ...
MONTVALE, N.J., Nov. 7, 2023 /PRNewswire/ -- EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) ("EOM") today provides an update on its clinical program for its lead drug candidate EOM613. EOM613 is a peptide-nucleic acid-based broad spectrum immune regulating agent that acts on both key ...